Literature DB >> 6693446

Indications for the treatment of deep venous thrombosis following total knee replacement.

P A Lotke, M L Ecker, A Alavi, H Berkowitz.   

Abstract

The diagnosis of deep venous thrombosis in the lower extremity has usually been thought to mandate the initiation of anticoagulation therapy. However, there has been evidence to show that this approach may not be necessary for deep venous thrombosis at or distal to the knee, and that the risks of treatment may be greater than those of the thrombosis itself. One hundred and seventy-five patients who underwent total knee replacement were examined postoperatively by venography, plethysmography, fibrinogen scans, and ventilation-perfusion lung scans. We found that 126 (72 per cent) of them had small or large clots in the calf, and that only forty-nine (28 per cent) had no thrombi. Seventy-one (41 per cent) of the patients had small thrombi in the calf and fifty-five (31 per cent) had large thrombi in the calf. Six patients had thrombi in the thigh, all of which were associated with large thrombi in the calf. In only two patients, however, did clinically recognized pulmonary emboli develop, one in the group of patients without known thrombi and the other in a patient with a large iliofemoral thrombus. The ventilation-perfusion scans showed six asymptomatic pulmonary emboli that were not associated with the presence of either large or small thrombi in the calf. The fibrinogen scans that were done in the postoperative period were capable of revealing large but not small thrombi in the calf. The preoperative plethysmography did not aid in determining in which patients a large thrombus of the calf or thigh was likely to develop.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693446

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  12 in total

Review 1.  Surgery of the rheumatoid knee.

Authors:  P J Abernethy
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

2.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

3.  Joint replacement in the elderly.

Authors:  T P Sculco; S E Powell
Journal:  Bull N Y Acad Med       Date:  1987-03

Review 4.  Distal deep vein thrombosis: what's the best treatment?

Authors:  L R Powers
Journal:  J Gen Intern Med       Date:  1988 May-Jun       Impact factor: 5.128

5.  The role of ultrasonography in thromboembolic disease management in the orthopaedic patient.

Authors:  W J Ciccone; J S Reid; V D Pellegrini
Journal:  Iowa Orthop J       Date:  1999

6.  Duplex ultrasonography after total hip or knee arthroplasty.

Authors:  P S Ko; W F Chan; T H Siu; A Cheng; O B Lee; J J Lam
Journal:  Int Orthop       Date:  2003-02-05       Impact factor: 3.075

7.  Incidence and management of pulmonary embolism following spinal surgery occurring while under chemical thromboprophylaxis.

Authors:  C Schizas; F Neumayer; V Kosmopoulos
Journal:  Eur Spine J       Date:  2008-04-18       Impact factor: 3.134

Review 8.  [Thrombosis prevention with heparin/dihydroergotamine versus heparin/Sintrom in Ender nailing of pertrochanteric fractures].

Authors:  G Schlag; T Gaudernak; H Pelinka; H Redl; H Kuderna; J Poigenfürst
Journal:  Unfallchirurgie       Date:  1988-02

9.  Effect on deep venous thrombosis with flexion during total knee arthroplasty.

Authors:  Geoffrey H Westrich; Raz Winiarsky; Michael Betsy; Lena Maun; Thomas P Sculco
Journal:  HSS J       Date:  2006-09

10.  Venous thromboembolism in Korean patients undergoing major orthopedic surgery: a prospective observational study using computed tomographic (CT) pulmonary angiography and indirect CT venography.

Authors:  Seung-Ick Cha; Shin-Yeop Lee; Chang-Ho Kim; Jae-Yong Park; Tae-Hoon Jung; Jae-Hyuck Yi; Jongmin Lee; Seung Huh; Hyun-Joo Lee; Shin-Yoon Kim
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.